Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal
2018 ◽
Vol 50
(9)
◽
pp. 944-953
◽
1998 ◽
Vol 30
(5)
◽
pp. 2073-2075
◽
Keyword(s):
2013 ◽
Vol 45
(8)
◽
pp. 3047-3051
◽
Keyword(s):